logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kenneth H. Shain

H. Lee Moffitt Cancer Center and Research Institute
H指数:41
被引数:7,057

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bridging therapy response and type as determinants of cilta-cel outcomes in relapsed/refractory multiple myeloma

桥接疗法反应类型作为复发/难治性多发性骨髓瘤中cilta-cel疗效的预测因素

Blood Cancer Journal
IF11.6
2026-10-010
OA
Doris K. Hansen; Brett M. Reid; Ariel Grajales-Cruz; Peter Cheng; Zhuoer Xie; Brandon Blue; Dae Hyun Lee; Laura Oswald; Gabriel De Avila; David Scheiber-Camoretti; Ken Harada; Daniel De Avila; Brandon Kale; Karla Feliciano Salva; David Kaldas; Kristy Matte; Todd Stinard; Rebecca Gonzalez; Victoria Alegria; Matthew Perciavalle; Helen Pai; Mukta Sharma; Kevin C. De Braganca; Zaina P. Qureshi; Fabiana Perna; Hien Liu; Kenneth H. Shain; Rachid Baz; Taiga Nishihori; Melissa Alsina; Ciara L. Freeman; Omar Alexis Castaneda Puglianini; Frederick L. Locke; Lauren C. Peres
Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma

UNC-51样激酶3（ULK3）在多发性骨髓瘤中的自噬和细胞存活中发挥作用

Nature Communications
IF15.7
2026-08-250
OAAI
Marilena Tauro; Tao Li; Praneeth R. Sudalagunta; Mark Meads; Rafael Renatino Canevarolo; Niveditha Nerlakanti; Raghunandan R. Alugubelli; Harshani R. Lawrence; Mukund P. Tantak; Steven Gunawan; Muhammad Ayaz; Pradeep Nareddy; Sang Young Yun; Gemma Shay; Yan Yang; Timothy H. Tran; Reginald Atkins; Frederick L. Locke; Ryan T. Bishop; Mostafa M. Nasr; Nicholas J. Lawrence; Ernst Schönbrunn; John L. Cleveland; Ariosto S. Silva; Kenneth H. Shain; Conor C. Lynch
Product-Intrinsic NF-κB–Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma

产品内在的NF-κB驱动的转录程序与多发性骨髓瘤中CAR-T应答的持久性相关

Blood
IF23.1
2026-06-220
PRE
Jerald D. Noble; Barbara C. Peixoto; Meghan A. Menges; Julieta Abraham-Miranda; Constanza Savid-Frontera; William Sawyer; Vasu D. Sorathia; Luis A Cuadrado Delgado; Salvatore A. Corallo; Julia C Llanos; Emily C. Merritt; Gabe de Avila; Omar A. Castaneda Puglianini; Hien Liu; Melissa Alsina; Taiga Nishihori; Kenneth H. Shain; Ariosto S. Silva; Rachid C. Baz; Brandon J. Blue
Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma

idecabtagene vicleucel与ciltacabtagene autoleucel CAR-T治疗多发性骨髓瘤后的患者报告结局

Bone Marrow Transplantation
IF5.2
2026-05-110
OAAI
Laura B. Oswald; Xiaoyin Li; Lisa M. Gudenkauf; Gabe De Avila; David Scheiber-Camoretti; Brent J. Small; Brian D. Gonzalez; Aasha I. Hoogland; Oanh Nguyen; Yvelise Rodriguez; Sylvia L. Crowder; Nathan H. Parker; Tiffany L. Carson; Christine E. Vinci; Rachid C. Baz; Kenneth H. Shain; Brandon Blue; Ariel Grajales-Cruz; Kristy Matte; Brandon Kale; David Kaldas; Fabiana Perna; Melissa Alsina; Ciara L. Freeman; Omar Castaneda Puglianini; Taiga Nishihori; Hien Liu; Frederick L. Locke; Heather S. L. Jim; Lauren C. Peres; Doris K. Hansen
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study

亲水胆汁酸对卡非佐米相关心血管事件因果效应的多发性骨髓瘤：一项孟德尔随机化研究

CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2026-02-010
OAAI
Samia Shabnaz; Eric Farber-Eger; Marwa Tantawy; Neyousha Shahisavandi; Timothy J. Garrett; Samuel M. Rubinstein; Michael G. Fradley; Mohammed E. Alomar; Danny DeAvila; Kenneth H Shain; R. Frank Cornell; Daniel Lenihan; Qing Lu; Quinn S Wells; Rachid C. Baz; Yan Gong
Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: Differences by race and ethnicity

Car-t治疗多发性骨髓瘤后患者报告结局的有意义变化: 种族和民族的差异

Blood Advances
IF7.1
2026-01-230
OAAI
Laura B. Oswald; Xiaoyin Li; Carina E. Ferraris; Gabe De Avila; David Scheiber-Camoretti; Lisa M. Gudenkauf; Brent J. Small; Brian D. Gonzalez; Aasha I. Hoogland; Oanh Nguyen; Yvelise Rodriguez; Sylvia L. Crowder; Nathan Parker; Tiffany L. Carson; Christine E. Vinci; Rachid C. Baz; Kenneth H. Shain; Brandon Blue; Ariel F. Grajales-Cruz; Kristy Matte
Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

西达基奥仑赛注射液（ciltacabtagene autoleucel）在重度预治疗复发或难治性多发性骨髓瘤患者中引发的细胞减少症和感染

Haematologica
IF7.9
2026-01-014
OA
Dima, Danai; Logue, Jennifer M.; Bin Waqar, Syed Hamza; Peres, Lauren C.; Colin-Leitzinger, Christelle M.; De Avila, Gabriel; Smith, Eric C.; Skelson, Lawrence; Matte, Kristy L.; Blue, Brandon; Hovanky, Vanna N.; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B.; Fortuna, Gliceida M. Galarza; Wagner, Charlotte B.; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L.; Shain, Kenneth H.; Baz, Rachid C.; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L.; Shune, Leyla O.; Sborov, Douglas W.; Patel, Krina K.; Sidana, Surbhi; Hansen, Doris K.
Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review

多发性骨髓瘤移植不合格定义不一致: 一项系统评价

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2026-01-010
OAAI
Neupane, Karun; Singstock, Mitch; Shah, Darshi; Dahal, Riyasha; Mian, Hira; Smith, Febe; Chakraborty, Rajshekhar; Al Hadidi, Samer; Mainou, Maria; Grajales-cruz, Ariel; Naqvi, Syeda Mahrukh Hussnain; Shain, Kenneth H.; Goodman, Aaron; Costa, Luciano J.; Qazilbash, Muzaffar; Mohyuddin, Ghulam Rehman
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma

开发靶向SEMA4A的CAR T细胞以克服多发性骨髓瘤中低BCMA抗原密度

Cancer Cell
IF44.5
2025-10-090
PRE
Francesco Di Meo; Francesca Albano; Annamaria Cesarano; Yunfei Wang; Brandon Kale; Kenneth Shain; Ariosto Silva; Noriyoshi Kurihara; Hirofumi Tenshin; David Jellyman; Xiaofei Song; Sasan Ghaffari; Hector Mesa; Ben Creelan; Ciara Freeman; Xiaohong Zhao; Mark B. Meads; Paulo C. Rodriguez; Silvia Marino; Frederick Locke; Patrick Hwu; David Roodman; Jorge Mansilla-Soto; Fabiana Perna
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses

达鲁单抗联合来那度胺维持治疗在新诊断的多发性骨髓瘤移植后的亚组分析

Blood Cancer Journal
IF11.6
2025-10-060
OA
Laahn Foster; Larry D. Anderson; Alfred Chung; Chakra P. Chaulagain; Erin Pettijohn; Andrew J. Cowan; Caitlin Costello; Sarah Larson; Douglas W. Sborov; Kenneth H. Shain; Rebecca Silbermann; Peter Voorhees; Maria Krevvata; Huiling Pei; Sharmila Patel; Vipin Khare; Annelore Cortoos; Robin Carson; Thomas S. Lin; Ashraf Badros
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy

靶抗原和浆细胞表型是对反应适应性达鲁珠单抗疗法的敏感性关键因素。

Blood
IF23.1
2025-09-240
PRE
Mark B. Meads; Xiaohong Zhao; David Noyes; Praneeth R. Sudalagunta; Alexandra Achille; Chaomei Zhang; Rafael R. Canevarolo; Maria Silva; Dario Magaletti; Daniel DeAvila; Sonila Toska; Ashley Oates; Daniel Lastorino; Dietrich Werner Idiaquez; Jinming Song; Samer S. Sansil; Sean J. Yoder; Ariel F. Grajales-Cruz; Brandon Blue; Ciara L. Freeman; Jongphil Kim; Melissa Alsina; Jason Brayer; Ariosto S. Silva; Xiaofei Song; Kenneth H. Shain; Rachid Baz
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

接受过BCMA靶向疗法的复发/难治性多发性骨髓瘤患者中teclistamab的治疗效果：一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

Blood Cancer Journal
IF11.6
2025-06-250
OAAI
Danai Dima; Mariola A. Vazquez-Martinez; James A. Davis; Utkarsh Goel; Aimaz Afrough; Aishwarya Sannareddy; Oren Pasvolsky; Beatrice Razzo; Rahul Banerjee; Jack Khouri; Ariel Grajales-Cruz; Alex Lieberman-Cribbin; Masooma Shifa Rana; Kelley Julian; Shaun DeJarnette; Andrew J. Portuguese; Mahmoud R. Gaballa; Gabriel De Avila; Sandra Susaniba Adaniya; Shahzad Raza; Megan M. Herr; Evguenia Ouchveridze; Tiffany Richards; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Omar Castaneda Puglianini; Adriana Rossi; Yi Lin; Shebli Atrash; Douglas Sborov; Kenneth H. Shain; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Doris K. Hansen; Surbhi Sidana; Krina K. Patel; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee; Faiz Anwer; Christopher J. Ferreri; Leyla Shune
Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma

增强的CAR-T细胞功能与线粒体健康性源自于多发性骨髓瘤中更早期的未分馏干细胞产品

Molecular Therapy
IF12
2025-04-180
PRE
Ciara L. Freeman; Julieta Abraham-Miranda; Meghan Menges; Reginald M. Atkins; Jerald Noble; Hien Liu; Salvatore Corallo; Luis A. Cuadrado Delgado; Albert J. Ribickas; Constanza Savid-Frontera; Gabriel de Avila; Omar A. Castaneda Puglianini; Jose Ochoa-Bayona; Doris K. Hansen; Melissa Alsina; Rachid Baz; Taiga Nishihori; Kenneth H. Shain; Frederick L. Locke
Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma

接受抗BCMA CAR-T治疗的复发性和难治性多发性骨髓瘤患者的心血管不良事件和结局

BLOOD CANCER JOURNAL
IF11.6
2025-04-140
OA
Palfi, Stefanie; Peres, Lauren C.; Koelmeyer, Himara; Alsina, Melissa; Baz, Rachid C.; Blue, Brandon J.; Corallo, Salvatore; De Avila, Gabriel; Freeman, Ciara; Gonzalez, Rebecca; Grajales-Cruz, Ariel; Harvey, Kristy; Liu, Hien D.; Nishihori, Taiga; Oliveira, Guilherme H.; Oswald, Laura B.; Castaneda Puglianini, Omar; Selvakumar, Sruthi; Sharma, Alexis Behne; Wang, Elicia; Shain, Kenneth H.; Jain, Michael; Locke, Frederick L.; Alomar, Mohammed; Hansen, Doris K.; Lee, Dae Hyun
Activity and Safety of Venetoclax (VEN)-Based Treatment in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM)

Venetoclax (VEN)为基础的治疗方案在t(11;14)-阳性复发/难治性多发性骨髓瘤(R/R MM)中的活性和安全性

BLOOD
IF23.1
2024-11-050
PRE
Ionescu, Filip; Thapa, Shrinjaya B.; Patel, Parth C.; Drekolias, Dimitrios; Silva, Ariosto Siqueira; Sudalagunta, Praneeth R.; Agius, Phaedra; Blue, Brandon; Hansen, Doris K.; Castaneda, Omar; Liu, Hien; Ochoa-Bayona, Jose L.; Freeman, Ciara Louise; Locke, Frederick; Nishihori, Taiga; Alsina, Melissa; Shain, Kenneth H.; Baz, Rachid; Grajales-Cruz, Ariel

研究方向

暂未获取到该数据
R
Rachid Baz
H 指数:43论文数:490被引数:8,431
M
Mark B. Meads
H 指数:17论文数:137被引数:2,487
M
Melissa Alsina
H 指数:64论文数:541被引数:1.8万
T
Taiga Nishihori
H 指数:53论文数:697被引数:9,964
W
William S. Dalton
H 指数:68论文数:257被引数:1.9万
A
Ariosto S. Silva
H 指数:17论文数:111被引数:2,284
P
Praneeth Sudalagunta
H 指数:9论文数:106被引数:446
B
Brandon Blue
H 指数:10论文数:126被引数:512
F
Frederick L. Locke
H 指数:61论文数:865被引数:3.1万
C
Ciara L. Freeman
H 指数:25论文数:287被引数:2,431